Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance Mutations

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2026-03-31
DOI
https://doi.org/10.1021/acs.jmedchem.6c00514
Primary Topic
Fibroblast Growth Factor Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance Mutations

Samhita Iyer, Jacqueline H. Starrett, Isaac Hoffman, Kirk Nelson et al.
Journal of Medicinal Chemistry
Fibroblast Growth Factor Research
article

Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance Mutations

Samhita Iyer, Jacqueline H. Starrett, Isaac Hoffman, Kirk Nelson, Alexandra Balcer, Melissa Neal, Ronald V. Swanson, Robert L. Hudkins, Daniel C. Bensen, Qing Ye, Todd J. Harris, Marc Rideout, Eric Allen, Caleb B. Frye
article en

Abstract

No abstract available for this paper.
Journal of Medicinal ChemistryVol. 69(7)
State Street (United States) (US), Nanospectra Biosciences (United States) (US)
Good health and well-being
Openalex Percentile: Top 31%
Fibroblast Growth Factor Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.